← Back to headlines
FDA Approves Eli Lilly's Oral Weight-Loss Pill Foundayo, Intensifying Competition
The U.S. Food and Drug Administration has approved Eli Lilly's new oral GLP-1 weight loss pill, Foundayo, offering a convenient alternative to injections and expanding market options while intensifying competition with Novo Nordisk's Wegovy.
1 Apr, 15:36 — 2 Apr, 12:15
The Story
Analyzing sources…
Source Diversity
Source Diversity
High (63/100)5 sources33/33
Spectrum spread— 3/5 buckets covered17/33
Far L2
Far Left (2)
NYTCNN
Left1
Left (1)
Yahoo
Center
Right2
Right (2)
capital-bgfaz
Far R
Geographic diversity— 3 regions13/34
US3Bulgaria1Germany1
Sources
Showing 3 of 5 sources
NYTMostly Factual3d ago
F.D.A. Approves New Eli Lilly Weight-Loss Pill, Foundayo
The drug, made by Eli Lilly, could offer a more convenient option for patients who want to avoid injections.
By Dani Blum and Rebecca Robbins
Read full article →CNNMostly Factual3d ago
Another GLP-1 weight loss pill gets FDA approval, and it has fewer restrictions on how it’s used - CNN
Another GLP-1 weight loss pill gets FDA approval, and it has fewer restrictions on how it’s used CNN
Read full article →YahooMostly Factual3d ago
GLP-1 wars: Lilly's FDA-approved oral weight-loss pill puts Novo Nordisk's Wegovy franchise under fresh pressure
Read full article →Coverage Timeline
First report: CNN · 1 Apr, 15:36|Full coverage: 5 · 21h|Window: 21h
Left-leaningCenterRight-leaning
